Adams Law

David G. Adams

T 202-670-2240

Areas of Practice
> Food and Drug Law

> Administrative Law
> Advertising and Marketing
> Legislative and Government Affairs

> Congressional Investigations

> Pharmaceuticals
> Consumer Products and Services
> Drugs, Medical Devices, and Biologics

> Dietary Supplements, Cosmetics, and Functional Foods
> Life Sciences

Government Experience
Associate Chief Counsel for Drugs, Food and Drug Administration

> Associate Chief Counsel for Enforcement, Food and Drug Administration

> Special Assistant United States Attorney, Office of the United States Attorney, Washington, D.C.

> Director, Policy Development and Coordination Staff, Food and Drug Administration

Judicial Clerkship
> Honorable Winston E. Arnow, Chief Judge, U.S. District Court for the Northern District of Florida, 1977-1978

Bar Admissions
> District of Columbia

Court Admissions
> U.S. Court of Appeals for the D.C. Circuit
U.S. Court of Appeals for the Fourth Circuit
> U.S. Court of Appeals for the Tenth Circuit
> U.S. District Court for the District of Columbia
> U.S. District Court for the District of Maryland
> U.S. District Court for the Northern District of Georgia

> Supreme Court of Georgia

> J.D., New York University School of Law, 1977
     - Root-Tilden Scholar
     - Research Editor, Annual

     Survey of American Law
> B.A., University of Louisiana - Lafayette, 1974

David Adams

Adams Law

1325 G St. NW, Suite 500
Washington, D.C. 20004


​​​About David Adams

David Adams is nationally recognized as a leading attorney in the Food and Drug bar.  He brings years of experience with the U.S. Food and Drug Administration to advise companies on product development, approval, and marketing.

His practice concentrates on FDA approval and marketing of human and veterinary drugs, devices, biologics, and tobacco products, as well as regulation of food and dietary supplements. 

He also represents clients before other agencies such as the Federal Trade Commission (FTC), and Drug Enforcement Administration (DEA), as well as before the courts, Congress and the National Advertising Division of the Better Business Bureaus (NAD).

His work encompasses:

  • regulatory counseling
  • lobbying
  • private business negotiation
  • litigation
  • advocacy before federal agencies and NAD
  • serving as expert witness

Prior to entering private practice, Mr. Adams held senior positions at the Food and Drug Administration including:

  • Associate Chief Counsel for Drugs, Office of the Chief Counsel
  • Associate Chief Counsel for Enforcement, Office of the Chief Counsel
  • Director of the Policy Development and Coordination Staff, Office of the Commissioner

He is recognized in The Best Lawyers in America for FDA Law.

Clients and Significant Matters

Mr. Adams represents manufacturers and distributors of prescription and over-the-counter medications, biologics, medical devices, tobacco products, foods, dietary supplements, and cosmetics.     He has also represented trade associations for FDA-regulated companies and medical and professional societies.

He has provided counsel on numerous complex regulatory issues before the FDA and has successfully represented his clients in: 

  • formal administrative appeals before FDA
  • complex litigation involving FDA’s approval processes and other regulatory issues
  • FTC, criminal, and Congressional investigations

He has also successfully lobbied Congress on important food and drug legislation.


The Best Lawyers in America, FDA Law, 2001-2019
U.S. News Best Lawyers Best Law Firms, 2017-2019
Washington DC Super Lawyers, 2013-2017 (Washington Post)
Who's Who Legal, 2014-2017
The International Who's Who of Life Sciences Lawyers, 2013-2014
"Washington’s Top Lawyers," 2011-2013 (Washingtonian magazine)
"Life Sciences Star," LMG Life Sciences 2012


Mr. Adams teaches Food and Drug Law at George Washington University Law School.
He is an editor of Food and Drug Law and Regulation, a food and drug law reference text.
He has served as chair of the Food and Drug Law Committee of the ABA Section of Business Law, as well as chair of the editorial board for the Food and Drug Law Journal.